Benchmark Holdings Regulatory News (BMK)

5 February 2016

BENCHMARK HOLDINGS PLC

("Benchmark" or the "Company" or the "Group")

DIRECTOR DEALINGS

The Company has been informed that Basil Brookes, Non-Executive Director, and his wife today purchased 5,000 ordinary shares each in Benchmark at a price of 63.97p per share.

Following this transaction, Basil's beneficial interest in the Company, including his wife's holding of 5,000 ordinary shares, is 49,062 ordinary shares, representing approximately 0.01 per cent. of the Company's issued share capital.

Notes to Editors:

Founded in 2000, Benchmark represents a new model in sustainable business development. Over the last decade it has built a profitable group of companies on the economics of a sustainable food chain. The Company is growing in response to a rapidly increasing demand for sustainable food chains, and in particular for seafood, from both mature and emerging markets.

Benchmark is an ethical company with an explicit policy based on the "3E's" definition of a sustainable business - ethics, environment and economics - which guides its strategy and operations.

The Group has five divisions: Animal Health which researches, manufactures and markets medicines and vaccines particularly for aquaculture, Sustainable Science which researches and informs sustainable development in the food industry, Technical Publishing which effects technology transfer through online publishing and education, Breeding & Genetics which comprises a world-leading Salmon and aquaculture breeding business, and Advanced Animal Nutrition which provides cutting edge nutritional products and services to the aquaculture industry. Benchmark operates internationally with offices in England, Scotland, Ireland, Norway, Iceland, Belgium, USA, Brazil, China, Moscow, India, Thailand and Chile. As at 1 February 2016, Benchmark employs 826 people.

For further information on Benchmark please visit www.benchmarkplc.com